RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis

Company Overview

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

Key Stats

• Today's Range: €11.90 to €12.30
• 50-Day Range: €11.80 to €15.90
• 52-Week Range: €9.50 to €14.00
• Volume: 718 shs
• Average Volume: 43,281 shs
• Market Capitalization: $797.57 million
• P/E Ratio: 17.78
• Dividend Yield: 1.25%
• Price Target: N/A
• Consensus Rating: N/A

RHK Stock Analysis - Frequently Asked Questions

How have RHK shares performed this year?

RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at €13.90 at the beginning of 2025. Since then, RHK stock has decreased by 13.7% and is now trading at €12.00.
View the best growth stocks for 2025 here.

What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some other companies that RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), Walt Disney (DIS), iShares Silver Trust (SLV), Alamos Gold (AGI), Anheuser-Busch InBev SA/NV (BUD) and Gilead Sciences (GILD).

Industry, Sector and Symbol

• Stock Exchange: ETR
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: ETR:RHK
• CIK: N/A
• Web: www.rhoen-klinikum-ag.com
• Phone: +49-9-771650
• Fax: N/A
• Employees: 18,324
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): €0.68
• Trailing P/E Ratio: 17.78
• Forward P/E Ratio: 40.34
• P/E Growth: 26.77
• Net Income: $44.55 million
• Net Margins: 2.90%
• Pretax Margin: N/A
• Return on Equity: 3.54%
• Return on Assets: 1.59%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.35
• Quick Ratio: 2.12

Sales & Book Value

• Annual Sales: $1.54 billion
• Price / Sales: 0.52
• Cash Flow: €4.36 per share
• Price / Cash Flow: 2.75
• Book Value: €19.58 per share
• Price / Book: 0.61

Miscellaneous

• Outstanding Shares: 66,463,759
• Free Float: N/A
• Market Cap: $797.57 million
• Optionable: Not Optionable
• Beta: -0.13